Diagnostic Accuracy of Lymph Nodes Fine Needle Aspiration Biopsy Based on The Sydney System for Reporting Lymph Node Cytology

Juanita, Juanita; Ikram, Dzul; Sungowati, Ni Ketut; Purnama, Imeldy Prihatni; Amalia, Amalia; Ningrati, Andi Ferial; Miskad, Upik Anderiani

doi:10.31557/APJCP.2023.24.6.1917

Diagnostic Accuracy of Lymph Nodes Fine Needle Aspiration Biopsy Based on The Sydney System for Reporting Lymph Node Cytology

Document Type : Research Articles

Authors

¹ Departement of Anatomical Pathology, Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia.

² Department of Anatomical Pathology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia.

³ Department of Histology, Faculty of Medicine, Universitas Muslim Indonesia, Makassar, Indonesia.

10.31557/APJCP.2023.24.6.1917

Abstract

Objective: To evaluate the diagnostic accuracy and malignancy risk of The Sydney System Reporting for Lymph Nodes Cytology. Material and methods: This study utilized secondary data from 156 cases to conduct a retrospective analysis of a diagnostic test method. During 2019–2021, data were collected at Dr. Wahidin Sudirohusodo’s Anatomical Pathology Laboratory in Makassar, Indonesia. The cytology slides of each case were split into five diagnostic groups using the Sydney method, which were then compared with the results of the histopathological diagnosis. Results: There were six cases in the L1 category, thirty-two cases in the L2 category, thirteen patients in the L3 category, seventeen cases in the L4 category, and ninety-one cases in the L5 class. The malignant probability (MP) is computed for each diagnostic classification. L1 MP value is 66.7%, L2 MP value is 15.6%, L3 MP value is 76.9%, L4 MP value is 94.0%, and L5 MP value is 98.9%. The diagnostic value of the FNAB examination is as follows: 89.9% sensitivity, 92.9% specificity, 98.2% positive predictive value, 68.4% negative predictive value, and 90.47% diagnostic accuracy. Conclusion: The FNAB examination provides high sensitivity, specificity, and accuracy in diagnosing lymph node tumors. Using a classification based on the Sydney system promotes communication between laboratories and clinicians.

Keywords